8ALP
Botulinum neurotoxin A6 cell binding domain crystal form II
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-10-16 |
Detector | DECTRIS EIGER2 XE 16M |
Wavelength(s) | 0.9795 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 39.554, 78.938, 118.550 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 65.705 - 1.500 |
Rwork | 0.248 |
R-free | 0.28930 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6two |
RMSD bond length | 0.010 |
RMSD bond angle | 1.547 |
Data reduction software | DIALS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 118.550 | 1.530 |
High resolution limit [Å] | 1.500 | 1.500 |
Rmerge | 0.119 | 5.680 |
Rpim | 0.023 | 1.125 |
Number of reflections | 60147 | 2894 |
<I/σ(I)> | 12 | 0.7 |
Completeness [%] | 99.6 | 97.5 |
Redundancy | 26.3 | |
CC(1/2) | 1.000 | 0.330 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 289.15 | 0.1 M magnesium acetate tetrahydrate, 0.1 M MES pH 6.5, 12% w/v of 50% PEG smear medium (4.55% v/v PEG 400, 4.55% v/v PEG 500 MME, 4.55% v/v PEG 600, 4.55% w/v PEG 1000, 4.55% w/v PEG 2000, 4.55% w/v PEG 3350, 4.55% w/v PEG 4000, 4.55% w/v PEG 5000 MME, 4.55% w/v PEG 6000, 4.55% w/v PEG 8000, 4.55% w/v PEG 10000) |